--ALX Oncology Holdings Inc.,, a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives, today announced that it will ...

In a world where AI and tech are reshaping industries from healthcare to finance, finding the right training can feel like searching for a needle in a digital ...

Jason Lettmann, Chief Executive Officer at ALX Oncology, will provide opening and closing remarks, highlighting progress and upcoming milestones for the company’s evorpacept clinical program.